Diagnostics
DNAe was named ‘Best Diagnostic Medtech Company’ at the 2018 OBN Awards.
Sysmex Inostics is pleased to announce publication of a study in the Journal of Molecular Oncology highlighting the important clinical value of blood-based ctDNA mutation testing to complement standard-of-care management of patients with advanced melanoma.
TIME Magazine came out with a list of the 50 most influential people in healthcare, dubbed The Health Care 50. A look through the list shows just how many ties and connections—as well as influence—this group has on the biopharma industry.
First public trial of DnaNudge’s technology has today been launched to study effects of DNA-based food choices for pre-diabetic individuals
Acquisition of Illumina NovaSeq instrument increases throughput & quality and reduces cost
Owlstone Medical today announces the appointment of Dr. Richard A Yost to its Scientific Advisory Board.
Medopad, a U.K.-based medical firm, and China-based Tencent Holdings, have teamed up on a project that will attempt to harness artificial intelligence in the diagnosis of Parkinson’s disease.
Guardant Health went on the Nasdaq yesterday under the symbol GH. Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO).
Epigenomics AG today announced that the U.S. Congress urges the Centers of Medicare & Medicaid Services (CMS) to consider coverage of colorectal cancer screening blood tests as part of the approved 2019 Health and Human Services (HHS) Appropriations Bill.
Karius today announced the winners for its 2018 Clinical Investigator Awards for Applied Infectious Disease Genomics.
PRESS RELEASES